1. Home
  2. TLN vs BBIO Comparison

TLN vs BBIO Comparison

Compare TLN & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TLN

Talen Energy Corporation

HOLD

Current Price

$304.58

Market Cap

15.7B

Sector

Utilities

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$78.68

Market Cap

15.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLN
BBIO
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7B
15.9B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
TLN
BBIO
Price
$304.58
$78.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
25
Target Price
$432.08
$86.33
AVG Volume (30 Days)
865.6K
2.1M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,581,000,000.00
$502,076,000.00
Revenue This Year
$59.63
$89.45
Revenue Next Year
$16.08
$73.78
P/E Ratio
N/A
N/A
Revenue Growth
22.03
126.26
52 Week Low
$301.45
$48.78
52 Week High
$451.28
$93.42

Technical Indicators

Market Signals
Indicator
TLN
BBIO
Relative Strength Index (RSI) 34.89 42.41
Support Level N/A $78.64
Resistance Level $405.34 $85.42
Average True Range (ATR) 15.44 2.55
MACD -3.11 -0.63
Stochastic Oscillator 5.01 5.94

Price Performance

Historical Comparison
TLN
BBIO

About TLN Talen Energy Corporation

Talen Energy Corp is an independent power producer and energy infrastructure company based in the United States. It owns and operates several gigawatts of power infrastructure in the United States, including 2.2GW of nuclear power and a dispatchable fossil fleet. The company produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, with its generation fleet principally located in the Mid-Atlantic, Ohio, and Montana. Talen's operating segments are: PJM and Others. The PJM segment, which generates maximum revenue, is engaged in electricity generation, marketing activities, and commodity risk and fuel management within the PJM market and is comprised of Susquehanna and Talen's natural gas and coal generation facilities in PJM.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: